Atlas Infectious Disease Practice

Welcome to Atlas Infectious Disease Practice, where your health and the well-being of the community are our top priorities. We take pride in our critical role in safeguarding public health by providing a comprehensive range of services focused on the diagnosis, treatment, management, and prevention of infectious diseases. Our dedicated team of physicians and healthcare professionals are committed to delivering expert care and guidance. Explore the services and affiliations that make us a trusted partner in your health journey

Our Mission

At Atlas Infectious Disease Practice, our mission is clear: to provide exceptional, compassionate care for patients with infectious diseases, utilizing cutting-edge diagnostics and treatments to improve health outcomes and quality of life.

We achieve this by addressing a broad spectrum of infectious diseases, including but not limited to HIV, tuberculosis, hepatitis, sexually transmitted diseases, respiratory infections, and more. Our holistic approach covers both the treatment of existing infections and the prevention of future ones while offering personalized attention and education to empower our patients in managing their conditions.

Services

Services Provided

Hospital Consultation

Office Consultation

Immigration Exams

Travel Consultation

Telemedicine

Yellow Fever Vaccine

HIV medicine

Sexually transmitted infection

employee health

IV infusion

Latest news

Stay Informed

Top 5 Infectious Disease News Stories Week of March 1-8

Top FDA Approvals and Updates from February 2025 in Infectious Disease In February 2025, several key FDA approvals and updates in infectious disease included the approval of Bavarian Nordic’s Vimkunya...

IMUNON’s IMNN-101 Vaccine Shows Promising Results in Phase 1 Trial, Demonstrates Cross-Reactivity Against COVID Variants

IMUNON, Inc, a clinical-stage company focused on developing non-viral DNA-based immunotherapies, has announced promising results from its Phase 1 proof-of-concept clinical trial of IMNN-101, a DNA...

Measles-Positive New Mexico Resident Dies, Cause of Death Still Unconfirmed

This is a developing story and will be updated as more information becomes available. Update March 7, 1:01pm ET: The Texas Department of State Health Services is reporting there have been 198 cases of...

An aerosol test for airborne bird flu

Recent outbreaks of highly pathogenic avian influenza (also known as bird flu) have created a need for rapid and sensitive detection methods to mitigate its spread. Now, researchers in ACS Sensors...

Insights from Investigator Evaluating Paxlovid’s Effectiveness in Vaccinated Older Adults

Katherine L Kahn, MD Image credits: UC Health Randomized clinical trials of nirmatrelvir-ritonavir (Paxlovid) have shown reduced COVID-19-related hospitalizations in unvaccinated individuals, but its...

Key Study Findings and Future Plans

Vaxart, Inc recently published complete data from its Phase 1b trial of its first-generation oral norovirus vaccine, demonstrating encouraging results in elderly adults. The study showed that the...

Cautionary Tale Associated in Trial With Rare Error in Cox Regression

The German company InflaRx has developed an investigational therapy, vilobelimab, which is being studied for SARS-CoV-2-induced acute respiratory distress syndrome (ARDS). Vilobelimab is a...

Vaxart Phase 1b Trial Shows 100% Increase in Serum Anti-VP1 IgA in Elderly Adults with Oral Norovirus Vaccine

Image credits: Vaxart Inc Vaxart, Inc announced the publication of complete data from its Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly adults. The trial...

Texas Outbreak Increases, Northeast Reports Cases, CDC Deployed to Help

On Tuesday, the Texas Department of State Health Services provided an update on the measles outbreak in there. Authorities reported there were 159 cases have been identified with 22 of the patients...

New antibodies show potential to defeat all SARS-CoV-2 variants

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep...

HIV Viral Suppression With Long-Acting Antiretroviral Therapy

This study uses electronic medical record data to compare 48-week viral load outcomes after starting...

Unintentional Fentanyl Use Detected in Hair

This study assessed hair samples to detect fentanyl exposure among people with or at risk of HIV...

Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants

This cohort study compares the bleeding risks among warfarin, rivaroxaban, and apixaban users in a...

Hepatitis C Virus Screening in Pregnant and Nonpregnant Women After Universal Screening Guidelines

This study examines whether hepatitis C virus screening differs among pregnant and nonpregnant...

Changes to CDC’s Website Threaten Patients, Public Health

This Medical News article discusses the impact of President Donald Trump’s executive orders on the...

IAS-USA Recommendations: Antiretrovirals for Treatment and Prevention of HIV in Adults

This Special Communication from the International Antiviral Society–USA provides updated 2024...

Advances in Treatment and Prevention of HIV

Advances in antiretroviral therapy (ART) has led to HIV being a manageable and preventable condition...

Jarisch-Herxheimer Reaction After Benzathine Penicillin G Treatment for Early Syphilis

This secondary analysis of a randomized clinical trial assesses the incidence of Jarisch-Herxheimer...

Elective Surgery for People With HIV With Low CD4 Count

This case report describes a man in his 60s with hypertension, deep vein thrombosis, and a recent...

DoxyPEP Shows Promise for Reducing STIs in 2 Studies

Amid the ongoing threat of sexually transmitted infections (STIs), doxycycline postexposure...

Communicable disease threats report, 1 – 7 March 2025, week 10

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1 – 7...

Communicable disease threats report, 22 – 28 February 2025, week 9

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 February...

Accepted insurances

Schedule appointment

We Are Dedicated To Your Health!

Better Care Starts With Us!

Testimonials

What Our Patients Say About Us!